Clover Corporation (ASX:CLV) Surges 18% as Margins Explode on a Europe-Led Mix Shift

The Business Model Upgrade Is Working

Clover Corporation surged 18% after releasing a very strong half-year result. Revenue reached A$44M, up 17%, while gross profit came in at A$15.7M, rising 54% and comfortably outpacing top-line growth.

That is a healthy result for a company of this size, and importantly it appears to be driven by real underlying demand rather than one-off factors. Both new and existing customers are buying more, while recent product launches are helping lift the mix toward higher-margin revenue.

Europe was the clear standout. Sales there jumped from A$10M to A$17M, showing that the new product strategy is gaining real traction in the region. Australia and New Zealand held relatively steady at A$20.2M, up 3%, while Asia was flat at A$5.7M. The Americas softened slightly, with revenue falling from A$1.8M to A$1.2M.

Europe is now Clover’s largest market, accounting for 39% of revenue, up from 28% a year earlier. That matters because European customers tend to be higher margin and more diversified, which makes this shift in revenue mix a positive one for the business.

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips

The Mix Shift Is Working

The product mix is the key driver of margin expansion. In FY24, Clover’s revenue base was still weighted toward lower-margin products such as legacy tuna oil. That is now shifting toward newer products, including non-allergenic powders, plant-based formats, and senior nutrition, which carry much stronger margins. These newer products made up 65% of H1 FY26 revenue.

The New Zealand processing and encapsulation facility is also now running at capacity. That matters because fixed overhead is being spread across a larger production base and a better product mix. When a manufacturing plant is operating at full utilisation, unit costs fall, and that has been an important driver of gross margin expansion..

The Working Capital Build Is Intentional

The company’s balance sheet has expanded through higher working capital investment as it prepares for continued demand, building inventory ahead of sales and supporting receivables growth.
The business also has no debt and around A$10M in cash, which leaves it looking to be in a healthy position from a financial standpoint.

H2 Needs to Deliver

Management’s FY26 revenue guidance sits at A$92M to A$96M.

The main downside risk is geopolitical disruption to supply chains, which management explicitly called out as an assumption behind that guidance. With crude fish oil sourced from Ecuador and products shipped to customers globally, Clover is not insulated from macro and logistics risk. Shipping costs and ocean freight conditions through Q3 FY26 will be important to watch.

For investors following the story, Clover appears to be in the middle of a genuine business model upgrade. Two years ago, it looked much more like a single-product, single-customer-type business. Today, it is generating stronger margins and revenue growth through a more successful and diversified product mix.

That said, with more capital now tied up in working capital, demand forecasts need to hold. If supply chain issues emerge while cash is sitting in inventory, the risk profile can change quickly.

The decline in America’s revenue is also worth monitoring, particularly if it reflects more intense competition in that market.